Intracellular Th Stock Price Prediction

ITCI Stock  USD 85.69  0.24  0.28%   
As of 24th of November 2024 The relative strength index (RSI) of Intracellular's share price is above 80 . This usually indicates that the stock is significantly overbought by investors. The fundamental principle of the Relative Strength Index (RSI) is to quantify the velocity at which market participants are driving the price of a financial instrument upwards or downwards.

Oversold Vs Overbought

80

 
Oversold
 
Overbought
The successful prediction of Intracellular's future price could yield a significant profit. We analyze noise-free headlines and recent hype associated with Intracellular Th, which may create opportunities for some arbitrage if properly timed. Below are the key fundamental drivers impacting Intracellular's stock price prediction:
EPS Estimate Next Quarter
(0.16)
EPS Estimate Current Year
(0.70)
EPS Estimate Next Year
0.2061
Wall Street Target Price
101.8667
EPS Estimate Current Quarter
(0.20)
Using Intracellular hype-based prediction, you can estimate the value of Intracellular Th from the perspective of Intracellular response to recently generated media hype and the effects of current headlines on its competitors.

Intracellular Th Hype to Price Pattern

Investor biases related to Intracellular's public news can be used to forecast risks associated with an investment in Intracellular. The trend in average sentiment can be used to explain how an investor holding Intracellular can time the market purely based on public headlines and social activities around Intracellular Th. Please note that most equities that are difficult to arbitrage are affected by market sentiment the most.
Some investors profit by finding stocks that are overvalued or undervalued based on market sentiment. The correlation of Intracellular's market sentiment to its price can help taders to make decisions based on the overall investors consensus about Intracellular.
The fear of missing out, i.e., FOMO, can cause potential investors in Intracellular to buy its stock at a price that has no basis in reality. In that case, they are not buying Intracellular because the equity is a good investment, but because they need to do something to avoid the feeling of missing out. On the other hand, investors will often sell stocks at prices well below their value during bear markets because they need to stop feeling the pain of losing money.

Intracellular after-hype prediction price

    
  USD 86.52  
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
  
Check out Intracellular Basic Forecasting Models to cross-verify your projections.
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Intracellular's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Intrinsic
Valuation
LowRealHigh
78.6980.7994.26
Details
Naive
Forecast
LowNextHigh
77.8079.8981.99
Details
16 Analysts
Consensus
LowTargetHigh
70.8377.8386.39
Details
Earnings
Estimates (0)
LowProjected EPSHigh
-0.27-0.18-0.09
Details

Intracellular After-Hype Price Prediction Density Analysis

As far as predicting the price of Intracellular at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in Intracellular or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Stock prices, such as prices of Intracellular, with the unreliable approximations that try to describe financial returns.
   Next price density   
       Expected price to next headline  

Intracellular Estimiated After-Hype Price Volatility

In the context of predicting Intracellular's stock value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on Intracellular's historical news coverage. Intracellular's after-hype downside and upside margins for the prediction period are 84.42 and 88.62, respectively. We have considered Intracellular's daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models outperform traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
85.69
86.52
After-hype Price
88.62
Upside
Intracellular is very steady at this time. Analysis and calculation of next after-hype price of Intracellular Th is based on 3 months time horizon.

Intracellular Stock Price Prediction Analysis

Have you ever been surprised when a price of a Company such as Intracellular is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Intracellular backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Intracellular, there might be something going there, and it might present an excellent short sale opportunity.
Expected ReturnPeriod VolatilityHype ElasticityRelated ElasticityNews DensityRelated DensityExpected Hype
  0.24 
2.10
  0.83 
  0.05 
8 Events / Month
8 Events / Month
In about 8 days
Latest traded priceExpected after-news pricePotential return on next major newsAverage after-hype volatility
85.69
86.52
0.97 
60.87  
Notes

Intracellular Hype Timeline

Intracellular Th is currently traded for 85.69. The entity has historical hype elasticity of 0.83, and average elasticity to hype of competition of 0.05. Intracellular is forecasted to increase in value after the next headline, with the price projected to jump to 86.52 or above. The average volatility of media hype impact on the company the price is about 60.87%. The price growth on the next news is projected to be 0.97%, whereas the daily expected return is currently at 0.24%. The volatility of related hype on Intracellular is about 1007.38%, with the expected price after the next announcement by competition of 85.74. The company reported the previous year's revenue of 464.37 M. Net Loss for the year was (139.67 M) with profit before overhead, payroll, taxes, and interest of 95.16 M. Given the investment horizon of 90 days the next forecasted press release will be in about 8 days.
Check out Intracellular Basic Forecasting Models to cross-verify your projections.

Intracellular Related Hype Analysis

Having access to credible news sources related to Intracellular's direct competition is more important than ever and may enhance your ability to predict Intracellular's future price movements. Getting to know how Intracellular's peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how Intracellular may potentially react to the hype associated with one of its peers.
Hype
Elasticity
News
Density
Semi
Deviation
Information
Ratio
Potential
Upside
Value
At Risk
Maximum
Drawdown
ALKSAlkermes Plc 0.50 10 per month 2.06 (0.03) 4.14 (3.59) 9.74 
IRWDIronwood Pharmaceuticals 0.38 7 per month 0.00 (0.12) 6.62 (7.54) 20.41 
DCPHDeciphera Pharmaceuticals LLC 0.00 0 per month 0.00 (0.15) 3.27 (3.25) 9.66 
PCRXPacira BioSciences,(0.34)10 per month 1.95  0.10  3.96 (3.21) 10.38 
COLLCollegium Pharmaceutical(0.86)9 per month 0.00 (0.16) 3.59 (4.47) 12.29 
EGRXEagle Pharmaceuticals 0.00 0 per month 0.00 (0.20) 9.24 (8.24) 53.71 
NBIXNeurocrine Biosciences 1.52 10 per month 0.00 (0.13) 3.10 (2.10) 19.06 
DVAXDynavax Technologies 0.51 8 per month 2.13  0.02  3.69 (2.93) 17.05 
AMPHAmphastar P 1.35 8 per month 0.00 (0.06) 3.37 (3.61) 17.30 
ANIPANI Pharmaceuticals(0.14)10 per month 0.00 (0.08) 3.70 (3.75) 10.82 
CYTHCyclo Therapeutics(0.04)5 per month 0.00 (0.08) 5.33 (5.19) 25.00 
AMRXAmneal Pharmaceuticals, Class 0.07 8 per month 1.75 (0.03) 3.03 (2.38) 11.27 
AQSTAquestive Therapeutics(0.24)7 per month 3.86  0.01  6.51 (7.14) 20.28 

Intracellular Additional Predictive Modules

Most predictive techniques to examine Intracellular price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Intracellular using various technical indicators. When you analyze Intracellular charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.

About Intracellular Predictive Indicators

The successful prediction of Intracellular stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published stock prices of traded companies, such as Intracellular Th, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at the intrinsic value of Intracellular based on analysis of Intracellular hews, social hype, general headline patterns, and widely used predictive technical indicators.
We also calculate exposure to Intracellular's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to Intracellular's related companies.
 2021 2022 2023 2024 (projected)
Days Sales Outstanding90.04110.1689.6271.42
PTB Ratio10.187.5911.617.67

Story Coverage note for Intracellular

The number of cover stories for Intracellular depends on current market conditions and Intracellular's risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that Intracellular is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about Intracellular's long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.

Intracellular Short Properties

Intracellular's future price predictability will typically decrease when Intracellular's long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of Intracellular Th often depends not only on the future outlook of the potential Intracellular's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Intracellular's indicators that are reflective of the short sentiment are summarized in the table below.
Common Stock Shares Outstanding95.9 M
Cash And Short Term Investments497.9 M

Complementary Tools for Intracellular Stock analysis

When running Intracellular's price analysis, check to measure Intracellular's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Intracellular is operating at the current time. Most of Intracellular's value examination focuses on studying past and present price action to predict the probability of Intracellular's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Intracellular's price. Additionally, you may evaluate how the addition of Intracellular to your portfolios can decrease your overall portfolio volatility.
Instant Ratings
Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance
FinTech Suite
Use AI to screen and filter profitable investment opportunities
Portfolio Dashboard
Portfolio dashboard that provides centralized access to all your investments
Theme Ratings
Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance
Commodity Channel
Use Commodity Channel Index to analyze current equity momentum
Stock Tickers
Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites
CEOs Directory
Screen CEOs from public companies around the world
Portfolio Comparator
Compare the composition, asset allocations and performance of any two portfolios in your account